Evaluation of NGS for Detection and Follow-up of Fungal Pathogens in Immunocompromised Pediatric Patients
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago
This observational or N/A phase trial investigates Fever and Neutropenia and Immunocompromised and is currently completed. Ann & Robert H Lurie Children's Hospital of Chicago leads this study, which shows 11 recorded versions since 2017 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 6 earlier versions
-
Jul 2019 — Nov 2020 [monthly]
Completed
-
Nov 2018 — Jul 2019 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Jun 2018 — Nov 2018 [monthly]
Active Not Recruiting
Status: Enrolling By Invitation → Active Not Recruiting
-
May 2018 — Jun 2018 [monthly]
Enrolling By Invitation
-
Apr 2018 — May 2018 [monthly]
Enrolling By Invitation
Phase: NA → None
-
Sep 2017 — Apr 2018 [monthly]
Enrolling By Invitation NA
First recorded
May 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ann & Robert H Lurie Children's Hospital of Chicago
- Karius, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .